IMMUCELL CORP. DL-10
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotaviru… Read more
Market Cap & Net Worth: IMMUCELL CORP. DL-10 (IUL)
IMMUCELL CORP. DL-10 (F:IUL) has a market capitalization of $50.14 Million (€48.85 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #23127 globally and #2522 in its home market, demonstrating a 0.93% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IMMUCELL CORP. DL-10's stock price €5.40 by its total outstanding shares 9045851 (9.05 Million).
IMMUCELL CORP. DL-10 Market Cap History: 2015 to 2026
IMMUCELL CORP. DL-10's market capitalization history from 2015 to 2026. Data shows change from $61.65 Million to $48.28 Million (-0.64% CAGR).
IMMUCELL CORP. DL-10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IMMUCELL CORP. DL-10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IUL by Market Capitalization
Companies near IMMUCELL CORP. DL-10 in the global market cap rankings as of March 19, 2026.
Key companies related to IMMUCELL CORP. DL-10 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
IMMUCELL CORP. DL-10 Historical Marketcap From 2015 to 2026
Between 2015 and today, IMMUCELL CORP. DL-10's market cap moved from $61.65 Million to $ 48.28 Million, with a yearly change of -0.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €48.28 Million | +1.96% |
| 2025 | €47.36 Million | +8.05% |
| 2024 | €43.83 Million | +6.79% |
| 2023 | €41.04 Million | -21.77% |
| 2022 | €52.46 Million | -24.67% |
| 2021 | €69.64 Million | +48.51% |
| 2020 | €46.89 Million | +16.90% |
| 2019 | €40.11 Million | -30.43% |
| 2018 | €57.66 Million | -8.58% |
| 2017 | €63.08 Million | +21.02% |
| 2016 | €52.12 Million | -15.45% |
| 2015 | €61.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of IMMUCELL CORP. DL-10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $50.14 Million USD |
| MoneyControl | $50.14 Million USD |
| MarketWatch | $50.14 Million USD |
| marketcap.company | $50.14 Million USD |
| Reuters | $50.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.